Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2022
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal CancerJames T Topham, Chris J O'Callaghan, Harriet Feilotter, et al.
Therapeutic Advances in Medical Oncology|December 22, 2022
Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapyJii Bum Lee, Hyung Soon Park, Su Jin Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 TrialJonathan M Loree, Emma Titmuss, James T Topham, et al.
Breast Cancer Research : BCR|April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.
JCO Precision Oncology|June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based TherapyJeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
The Lancet. Respiratory Medicine|April 3, 2019
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyMadeleine K D Scott, Katie Quinn, Qin Li, et al.
Pageof 2